Live Music Spending in 2025 Consumers Turn Intentional Amid Rising Prices and Blue Dot Fever Nifty Midcap 100 Hits Record High for Fourth Straight Session Analysts Point to Potential 20 Upside Nvidia Earnings Spotlight Jensen Huangs China Chip Comments in Focus After Xi Summit Geopolitical Tensions Escalate as Trump Rejects Irans Peace Counteroffer Risking Global Energy Markets Marvell Technology Shares Surge on Accelerating AIDriven Revenue Growth Outlook IEA Report Global Electric Car Sales Surpass 20 Million in 2025 Signaling Shift in Energy Landscape SNFCA Q4 2025 Earnings EPS of 053 Highlights Profitability Amidst Steady Operations WVE Q1 2026 Earnings EPS Beat with 607 Surprise Shares Dip PSX Q1 2026 Earnings Strong Earnings Surprise Driven by Improved Refining Margins NOW Q1 2026 Earnings Slight EPS Miss Overshadowed by Positive Stock Reaction Globant Q1 2026 Earnings EPS Misses Estimates Stock Declines Slightly QBTS Q1 2026 Earnings Strong EPS Beat Highlights Progress in Quantum Computing MetLife Inc MET Holds Steady Near 84 as Broader Market Volatility Persists Citizens Financial Group Edges Higher CFG Nears Resistance Amid Positive Momentum Centurion Acquisition Corp ALF Hovers Near Trust Value as SPAC Awaits Catalyst PennantPark Investment Corporation PNNT Stages a Modest Rebound Near Key Support Neptune Insurance Holdings NP Holds Steady Above Support Despite Thin Gains EU Parliament Approves US Tariff Deal Amid Ongoing Trump Pressure South Koreas Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Unrest Charter Communications Enhances Offer for Liberty Broadband in Revised Takeover Deal BJs Wholesale Club BJ Reports Q2 2025 Results Earnings Call Highlights Key Strategic Initiatives Microsofts AI Adoption Reveals Costly Paradox Automation May Be More Expensive Than Human Labor USChina Trade Relations APEC Meetings Reveal Persistent Divergence in Priorities EU Weighs New Trade Defenses as China Trade War Threatens Key Sectors LSAK Q1 2026 Earnings Stunning EPS Surprise of 97843 as Company Reports 011 vs 00102 Estimate Xeris Biopharma XERS Declines 298 as Stock Tests Key Support Levels